X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-13 | CDTX | Ward Shane | COO, CLO | S - Sale | $1.53 | -4,329 | 84,576 | -5% | -$6,623 | ||||||
2023-03-13 | CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S - Sale | $1.53 | -7,562 | 191,663 | -4% | -$11,570 | ||||||
2023-03-13 | CDTX | Shah Preetam | CFO, CBO | S - Sale | $1.53 | -6,648 | 148,141 | -4% | -$10,171 | ||||||
2023-03-13 | CDTX | Sandison Taylor | Chief Medical Officer | S - Sale | $1.53 | -7,203 | 288,550 | -2% | -$11,021 | ||||||
2023-01-12 | CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S - Sale | $1.20 | -11,814 | 199,225 | -6% | -$14,177 | ||||||
| D | 2022-09-19 | CDTX | Shah Preetam | CFO, CBO | S - Sale+OE | $0.77 | -15,642 | 150,789 | -9% | -$12,035 | |||||
2022-09-12 | CDTX | Sandison Taylor | Chief Medical Officer | S - Sale | $0.68 | -18,478 | 291,753 | -6% | -$12,656 | ||||||
2022-09-12 | CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S - Sale | $0.68 | -18,159 | 207,039 | -8% | -$12,437 | ||||||
2022-09-12 | CDTX | Daruwala Paul | COO | S - Sale | $0.68 | -16,199 | 221,099 | -7% | -$11,095 | ||||||
2022-03-21 | CDTX | Johnson Brady | VP, Finance | S - Sale | $0.81 | -654 | 49,366 | -1% | -$530 | ||||||
2022-03-11 | CDTX | Johnson Brady | VP, Finance | S - Sale | $0.71 | -945 | 50,020 | -2% | -$671 | ||||||
| D | 2022-01-05 | CDTX | Daruwala Paul | COO | S - Sale+OE | $1.25 | -5,133 | 187,298 | -3% | -$6,416 | |||||
| D | 2022-01-05 | CDTX | Johnson Brady | VP, Finance | S - Sale+OE | $1.25 | -416 | 50,965 | -1% | -$520 | |||||
| D | 2022-01-05 | CDTX | Tari Leslie | Chief Scientific Officer | S - Sale+OE | $1.25 | -1,252 | 168,698 | -1% | -$1,565 | |||||
2021-11-12 | CDTX | Stein Jeffrey | Pres, CEO | P - Purchase | $1.59 | +50,000 | 739,489 | +7% | +$79,530 | ||||||
2021-11-12 | CDTX | Shah Preetam | CFO, CBO | P - Purchase | $1.54 | +20,000 | 20,000 | New | +$30,800 | ||||||
2021-09-13 | CDTX | Franson Timothy R | Dir | P - Purchase | $2.12 | +7,000 | 11,000 | +175% | +$14,823 | ||||||
| M | 2021-08-18 | CDTX | Stein Jeffrey | Pres, CEO | P - Purchase | $1.74 | +50,000 | 689,489 | +8% | +$86,755 | |||||
| M | 2021-01-05 | CDTX | Abdollahian Neil | Chief Business Officer | S - Sale | $2.26 | -4,337 | 57,471 | -7% | -$9,816 | |||||
| M | 2021-01-05 | CDTX | Daruwala Paul | COO | S - Sale | $2.16 | -3,461 | 50,531 | -6% | -$7,485 | |||||
| M | 2021-01-05 | CDTX | Oien Jessica | GC, Secretary | S - Sale | $2.41 | -2,001 | 7,764 | -20% | -$4,828 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |